NINGBO INNO PHARMCHEM CO., LTD. is pleased to present Citicoline Sodium (CAS 33818-15-4) as a cornerstone pharmaceutical intermediate for the development of advanced neurological therapies. This high-purity compound is essential for manufacturers aiming to create effective treatments for a range of central nervous system disorders.

As a central nervous system medication, Citicoline Sodium is instrumental in the management of acute brain injuries and post-operative consciousness issues. Its therapeutic application also extends to aiding the functional recovery of limbs in patients affected by strokes, making it a key component in stroke rehabilitation treatment. The ongoing demand for sophisticated brain injury recovery medication highlights the critical role of intermediates like Citicoline Sodium in the pharmaceutical supply chain.

Our commitment at NINGBO INNO PHARMCHEM CO., LTD. is to supply Citicoline Sodium that meets stringent pharmaceutical standards, available in CP, BP, and USP grades. Manufacturing processes are overseen by partners adhering to GMP and FDA regulations, ensuring the highest levels of quality and safety. For businesses seeking a reliable central nervous system medication supplier, our adherence to these global standards is a significant advantage.

The compound's potential is further recognized in addressing conditions like vascular dementia and ischemic cerebrovascular disease, where it supports neuronal health and function. This broadens its application for companies focused on developing innovative brain health supplements ingredients. We understand the importance of sourcing high-quality pharmaceutical raw materials for CNS disorders, and Citicoline Sodium is a prime example of our commitment to this sector.

NINGBO INNO PHARMCHEM CO., LTD. supports your R&D efforts by providing samples and comprehensive technical documentation. By choosing our Citicoline Sodium, you are investing in a critical component that can drive innovation in neurological treatments and improve patient care. Let us be your trusted partner in developing the next generation of neurological therapies.